Why the study?
Does initial COVID-19 disease severity predict persistent symptoms in COVID-19 survivors?
Does initial COVID-19 disease severity predict persistent symptoms in COVID-19 survivors?
Initial COVID-19 disease severity does not predict most persistent symptoms, indicating all survivors are at risk regardless of acute phase severity.
Long-term symptom surveillance warranted for all COVID-19 survivors regardless of acute severity; challenges severity-based risk stratification for most persistent symptoms.
Contrary to expectations, we did not observe an association between the initial COVID-19 disease severity and common persistent symptoms except for dyspnea and fatigue. In addition, it was found that being in the acute or prolonged post-COVID phase did not affect the risk of symptoms. Primary care providers should be alert to potential most prevalent persistent symptoms in all COVID-19 survivors, which are not limited to patients with critical-severe initial disease.
No takes yet. Share an insight, caveat, or question.
Dirican et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: